Evonik launches EUDRACAP® colon functional capsules in GMP quality at CPHI Frankfurt
Launched last year, EUDRACAP® colon is the first functional, ready-to-fill capsule specifically designed to target the ileo-colonic region. ... MORE
PRESS RELEASES
Find the latest news from our company.
Evonik and Ethris enter strategic partnership to expand offerings for nucleic acid delivery
Evonik and Ethris, a clinical-stage biotechnology company have entered into a strategic collaboration to develop and market a novel lipid nanoparticle (LNP) platform for nucleic acid delivery. ... MORE
Evonik receives Best Bioprocessing Supplier Award for cell culture solutions
The award recognizes Evonik’s strong cell culture ingredients portfolio that includes cQrex® peptides, the plant-based cholesterol PhytoChol®, as well as R&D, formulation and process expertise. ... MORE
Evonik partners with ST Pharm to increase its offerings for RNA and nucleic acid delivery
Evonik increases speed to market for drug developers working on nucleic acid therapeutics ... MORE
Evonik to restructure its keto and pharma amino acid business
Evonik is transforming its Health Care business to focus on its strategic core growth areas. ... MORE
Evonik wins CPHI Pharma Award for its plant-based squalene PhytoSquene®
Evonik has won this year’s CPHI Pharma Award in the category “Sustainability”. The winning innovation is the plant-based squalene, PhytoSquene®, which can be used for parenteral drug delivery applications, and is the first plant-based squalene in GMP quality. ... MORE
More releases
-
Oct 02, 2024Health Care
-
Sep 25, 2024Health Care
-
Sep 10, 2024Health Care
-
Sep 10, 2024Health Care
-
Aug 13, 2024Evonik expands its formulation capabilities for lipid nanoparticles used for mRNA and gene therapiesHealth Care
-
Jul 01, 2024Personnel News
-
May 14, 2024Health Care
-
Mar 21, 2024Health Care
-
Mar 14, 2024Health Care